Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate

SAN DIEGO and SILVER SPRING, Md., Sept. 17, 2018 -- (Healthcare Sales & Marketing Network) -- Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation (Nasdaq :UTHR ) for North American rights to Samumed's SM04646, being... Biopharmaceuticals, Licensing United Therapeutics, Samumed, idiopathic pulmonary fibrosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news